Jury sides with Abbott Laboratories in ongoing fight over preterm infant formulas
A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not liable after a boy consumed the companies’ cow’s milk-based products for premature infants and became severely ill.
Abbott, Reckitt found not liable in baby formula case. Stocks rise.
A Missouri jury found Abbott Laboratories (ABT) and a unit of Reckitt Benckiser (RBGLY) not responsible for an infant death originally claimed to be tied to the company's baby formulas. The two health companies are seeing their shares rise on Friday following this legal victory.
Tribune News Service on MSN20h
Hundreds of lawsuits allege Abbott Laboratories’ formula for premature infants made babies sick. But is the formula to blame?To Dioselina Salto, the first two weeks of motherhood were amazing, even though she spent much of it in the hospital after ...
Missouri Judge Sanctions Kirkland Lawyer, Barring Him from Abbott Infant Formula Trial Over Alleged Misconduct in High-Stakes NEC Case ...
Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...
CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...
Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive ...
Abbott Laboratories showcases robust financial performance with a notable increase in net earnings. Strategic acquisitions and product launches strengthen the company's market presence.
Barclays analyst Matt Miksic raised the firm’s price target on Abbott (ABT) to $149 from $143 and keeps an Overweight rating on the ...
Abbott Laboratories (NYSE:ABT) rose 6% in after hours trading after a jury found the company and a Reckitt Benckiser ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback